Home PharmEasy aims to raise Rs 3,500 Cr via right issue, faces valuation slash

PharmEasy aims to raise Rs 3,500 Cr via right issue, faces valuation slash

API Holdings Limited, owner of PharmEasy, leans on existing investors to raise Rs 3,500 Cr due to market challenges.
This financing round, including potential investment of Rs 1,200 Cr from Ranjan Pai’s family office, will repay a Goldman Sachs term loan.
PharmEasy valuation sinks by almost 50%, expected to reach around $500 million pre-money in the new round.